Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Q Lacy

Showing results (21-30 of 142) with videos related to

Pageof 15
Sort By:
Neurology|November 18, 1998
Transthyretin amyloidosis (serine 44) with headache, hearing loss, and peripheral neuropathyC J Klein, M Nakumura, D R Jacobson, et al.
Medical Oncology (Northwood, London, England)|August 24, 1999
Phase II trial of high-dose dexamethasone for untreated patients with primary systemic amyloidosisM A Gertz, M Q Lacy, J A Lust, et al.
American Journal of Hematology|June 15, 1999
Phase II trial of high-dose dexamethasone for previously treated immunoglobulin light-chain amyloidosisM A Gertz, M Q Lacy, J A Lust, et al.
Bone Marrow Transplantation|March 21, 2007
Impact of age and serum creatinine value on outcome after autologous blood stem cell transplantation for patients with multiple myelomaM A Gertz, M Q Lacy, A Dispenzieri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Prospective randomized trial of melphalan and prednisone versus vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of primary systemic amyloidosisM A Gertz, M Q Lacy, J A Lust, et al.
Bone Marrow Transplantation|September 12, 2007
Transplantation without growth factor: engraftment kinetics after stem cell transplantation for primary systemic amyloidosis (AL)M A Gertz, M Q Lacy, A Dispenzieri, et al.
Blood Cancer Journal|October 27, 2015
Characteristics of exceptional responders to lenalidomide-based therapy in multiple myelomaT Vu, W Gonsalves, S Kumar, et al.
British Journal of Haematology|May 3, 2000
Waldenström's macroglobulinaemia: a prospective study comparing daily with intermittent oral chlorambucilR A Kyle, P R Greipp, M A Gertz, et al.
Blood|January 28, 1999
Long-term survival (10 years or more) in 30 patients with primary amyloidosisR A Kyle, M A Gertz, P R Greipp, et al.
Cancer|June 15, 1995
c-erbB-2 and p53 expression in fallopian tube carcinomaM Q Lacy, L C Hartmann, G L Keeney, et al.
Pageof 15

Showing results (21-30 of 142) with videos related to

Sort By:
Pageof 15
Neurology|November 18, 1998
Transthyretin amyloidosis (serine 44) with headache, hearing loss, and peripheral neuropathyC J Klein, M Nakumura, D R Jacobson, et al.
Medical Oncology (Northwood, London, England)|August 24, 1999
Phase II trial of high-dose dexamethasone for untreated patients with primary systemic amyloidosisM A Gertz, M Q Lacy, J A Lust, et al.
American Journal of Hematology|June 15, 1999
Phase II trial of high-dose dexamethasone for previously treated immunoglobulin light-chain amyloidosisM A Gertz, M Q Lacy, J A Lust, et al.
Bone Marrow Transplantation|March 21, 2007
Impact of age and serum creatinine value on outcome after autologous blood stem cell transplantation for patients with multiple myelomaM A Gertz, M Q Lacy, A Dispenzieri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Prospective randomized trial of melphalan and prednisone versus vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of primary systemic amyloidosisM A Gertz, M Q Lacy, J A Lust, et al.
Bone Marrow Transplantation|September 12, 2007
Transplantation without growth factor: engraftment kinetics after stem cell transplantation for primary systemic amyloidosis (AL)M A Gertz, M Q Lacy, A Dispenzieri, et al.
Blood Cancer Journal|October 27, 2015
Characteristics of exceptional responders to lenalidomide-based therapy in multiple myelomaT Vu, W Gonsalves, S Kumar, et al.
British Journal of Haematology|May 3, 2000
Waldenström's macroglobulinaemia: a prospective study comparing daily with intermittent oral chlorambucilR A Kyle, P R Greipp, M A Gertz, et al.
Blood|January 28, 1999
Long-term survival (10 years or more) in 30 patients with primary amyloidosisR A Kyle, M A Gertz, P R Greipp, et al.
Cancer|June 15, 1995
c-erbB-2 and p53 expression in fallopian tube carcinomaM Q Lacy, L C Hartmann, G L Keeney, et al.
Pageof 15